Concord Investment Counsel Inc. Invests $9.97 Million in UnitedHealth Group Incorporated $UNH

Key Points

• Concord Investment Counsel initiated a $9.97 million position in UnitedHealth Group during the second quarter, purchasing 24,054 shares. The stock represents approximately 2.7% of Concord’s portfolio, while institutional investors collectively own 87.86% of UNH.
• Analysts remain broadly positive, with UnitedHealth receiving a “Moderate Buy” consensus rating and an average price target of $455.92. Recent targets range from $380 to $516, while the company exceeded quarterly earnings expectations with $6.38 in EPS versus a $4.94 consensus.
• UnitedHealth declared a quarterly dividend of $2.32 per share, equivalent to $9.28 annually and a 2.4% yield. However, rising health-care costs and CEO Patrick Hugh Conway’s sale of 500 shares present potential concerns for investors.

Concord Investment Counsel Inc. purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor purchased 24,054 shares of the healthcare conglomerate's stock, valued at approximately $9,970,000. UnitedHealth Group comprises about 2.7% of Concord Investment Counsel Inc.'s portfolio, making the stock its 17th largest position.

Other institutional investors also recently added to or reduced their stakes in the company. Sarver Vrooman Wealth Advisors bought a new position in UnitedHealth Group during the fourth quarter valued at about $25,000. Anfield Capital Management LLC boosted its stake in UnitedHealth Group by 220.0% in the 4th quarter. Anfield Capital Management LLC now owns 80 shares of the healthcare conglomerate's stock worth $26,000 after purchasing an additional 55 shares during the period. Joseph Group Capital Management purchased a new stake in UnitedHealth Group in the 4th quarter worth about $27,000. Nalls Sherbakoff Group LLC purchased a new position in UnitedHealth Group during the fourth quarter valued at approximately $27,000. Finally, Lifetime Wealth Management P.C. acquired a new position in shares of UnitedHealth Group in the fourth quarter worth $29,000. Institutional investors and hedge funds own 87.86% of the company's stock.

Analysts Set New Price Targets

UNH has been the subject of several research reports. Barclays lifted their price target on UnitedHealth Group from $429.00 to $441.00 and gave the company an "overweight" rating in a report on Monday, July 20th. JPMorgan Chase & Co. lifted their target price on shares of UnitedHealth Group from $466.00 to $516.00 and gave the company an "overweight" rating in a research note on Tuesday, July 21st. HSBC increased their price target on shares of UnitedHealth Group from $300.00 to $380.00 and gave the stock a "hold" rating in a research note on Monday, July 6th. Piper Sandler set a $477.00 price objective on shares of UnitedHealth Group in a report on Thursday, July 16th. Finally, Leerink Partners boosted their price target on UnitedHealth Group from $400.00 to $462.00 and gave the stock an "outperform" rating in a research report on Wednesday, June 17th. Two analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, UnitedHealth Group has an average rating of "Moderate Buy" and an average price target of $455.92.

UnitedHealth Group News Summary

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth is reportedly prioritizing Medicare Advantage profitability over rapid membership growth by tightening benefits, improving pricing and controlling costs. The strategy could support stronger margins and more sustainable earnings, even if enrollment growth moderates. Is UnitedHealth Finding a Better Path to Medicare Advantage Growth?
• Positive Sentiment: Zacks Research added UNH to its Rank #1, or “Strong Buy,” lists for overall stocks, value stocks and income stocks. The repeated favorable rankings may reinforce investor confidence in the shares. New Strong Buy Stocks for August 21st
• Positive Sentiment: Analysts raised several forward EPS estimates, including Q1 2028 to $7.36 from $6.78 and Q2 2028 to $7.19 from $5.84. A separate report also noted an increase in the Q1 EPS estimate, while Zacks maintained a Strong Buy rating. Q1 EPS Estimate for UnitedHealth Group Increased by Analyst
• Neutral Sentiment: Forecast revisions were mixed: Q3 2027 EPS was reduced to $4.74 from $4.81 and Q4 2027 to $4.07 from $4.12, partially offsetting the increases for 2028.
• Negative Sentiment: Aon expects U.S. employer health-care costs to rise 9.5% in 2027. Persistent medical-cost inflation could pressure insurers’ margins and increase pricing, benefit and utilization-management challenges for UnitedHealth. AON Sees No Relief From Health-Cost Inflation

UnitedHealth Group Stock Up 0.2%

NYSE UNH opened at $390.94 on Monday. UnitedHealth Group Incorporated has a twelve month low of $255.96 and a twelve month high of $461.62. The company has a debt-to-equity ratio of 0.66, a quick ratio of 0.78 and a current ratio of 0.78. The stock has a market cap of $350.90 billion, a PE ratio of 25.16, a PEG ratio of 1.35 and a beta of 0.62. The firm has a 50-day simple moving average of $413.99 and a 200 day simple moving average of $356.45.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its quarterly earnings data on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, topping analysts' consensus estimates of $4.94 by $1.44. The company had revenue of $112.03 billion during the quarter, compared to the consensus estimate of $110.81 billion. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The company's quarterly revenue was up .4% on a year-over-year basis. During the same quarter last year, the company earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. On average, research analysts forecast that UnitedHealth Group Incorporated will post 19.81 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 22nd. Shareholders of record on Monday, September 14th will be issued a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.4%. The ex-dividend date of this dividend is Monday, September 14th. UnitedHealth Group's payout ratio is presently 59.72%.

Insider Activity

In related news, CEO Patrick Hugh Conway sold 500 shares of the business's stock in a transaction on Wednesday, August 5th. The stock was sold at an average price of $410.00, for a total value of $205,000.00. Following the sale, the chief executive officer owned 16,497 shares of the company's stock, valued at $6,763,770. The trade was a 2.94% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 0.19% of the company's stock.

UnitedHealth Group Company Profile

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source